Analytical Data
-
Gene name
MCP
- Application
-
Alternative Names
MCP；MCP；MIC10；Membrane cofactor Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P15529
-
Expression Region
35-328aa
-
AA Sequence
CEEPPTFEAMELIGKPKPYYEIGERVDYKCKKGYFYIPPLATHTICDRNHTWLPVSDDACYRETCPYIRDPLNGQAVPANGTYEFGYQMHFICNEGYYLIGEEILYCELKGSVAIWSGKPPICEKVLCTPPPKIKNGKHTFSEVEVFEYLDAVTYSCDPAPGPDPFSLIGESTIYCGDNSVWSRAAPECKVVKCRFPVVENGKQISGFGKKFYYKATVMFECDKGFYLDGSDTIVCDSNSTWDPPVPKCLKVLPPSSTKPPALSHSVSTSSTTKSPASSASGPRPTYKPPVSNY
-
Molecular Weight
61.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of MCP (Main Capsid Protein) recombinant proteins is vital in the field of virology and vaccine development. MCPs are key structural components of viral capsids, playing a crucial role in the protection of viral genetic material and facilitating the infection process by mediating host cell interactions. Understanding the structure and function of MCPs can unveil insights into viral assembly, stability, and immune response mechanisms. With the advancements in recombinant DNA technology, it is now possible to produce MCPs in prokaryotic or eukaryotic systems, enabling researchers to generate large quantities of these proteins for detailed analysis. The isolation and characterization of MCPs aid in the development of novel vaccines and diagnostic tools for viral diseases. Furthermore, recombinant MCPs can be utilized as a platform for the presentation of foreign antigens, allowing for the design of multi-epitope vaccines. As emerging viruses continue to pose significant public health challenges, research on MCP recombinant proteins contributes to the growing arsenal of strategies aimed at preventing and controlling viral infections, highlighting their importance in both basic and applied sciences.
